External quality control of Mycobacterium tuberculosis drug susceptibility testing: Results of two rounds in endemic countries

International Journal of Tuberculosis and Lung Disease

Volumn 12, Issue 2, 2008, Pages 214-217

  Fattorini, Lanfranco ^a   Iona, E ^a   Cirillo, D ^b   Migliori, G B ^c   Orefici, G ^a   Aziz, M ^d   Wright, A ^d   Tafaj, S ^e   Baig, B ^f   Mulliqi, G ^g   Maungate, S ^h   Cuna, Z ^h   Al Busaidy, S ⁱ   Al Suwaidi, Z ^j   Ceyhan, I ^k  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c IRCCS   (Italy)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

^e UNIVERSITY HOSPITAL CENTER MOTHER TERESA   (Albania)

^f National Reference Laboratory   (Bahrain)

^g National Institute of Public Health   (Serbia)

^h Laboratorio National de Referenda da TB/Lepra   (Mozambique)

ⁱ Central Public Health Laboratory   (Oman)

^j Department of Laboratory Medicine and Pathology ^*  (Qatar)

^k National Food Reference Laboratory   (Turkey)

more..

Author keywords

Drug susceptibility testing; External quality control; Mycobacterium tuberculosis; WHO Union Supranational Reference Laboratories

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM DETECTION; CONTROLLED STUDY; DRUG SENSITIVITY; LABORATORY TEST; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; QUALITY CONTROL; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS; WORLD HEALTH ORGANIZATION;

ANTITUBERCULAR AGENTS; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; QUALITY CONTROL; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS, PULMONARY;

EID: 38949204886     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. World Health Organization (WHO). The WHO/International Union Against Tuberculosis and Lung Disease Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Anti-tuberculosis drug resistance in the world. Report No. 3.WHO/CDSATB/2004.343. Geneva, Switzerland: WHO, 2004: pp 1-129.
2. Aziz M A, Wright A, Laszlo A, et al. Epidemiology of anti-tuberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis. Lancet 2006; 368: 2142-2154.
3. Aziz M A, Wright A. The World Health Organization/International Union Against Tuberculosis and Lung Disease Global Project on Surveillance for Anti-Tuberculosis Drug Resistance: a model for other infectious diseases. Clin Infect Dis 2005; 41 (Suppl): S258-S262.
4. Laszlo A, Rahman M, Raviglione M, Bustreo F, and the WHO/IUATLD Network of Supranational Reference Laboratories. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing. Int J Tuberc Lung Dis 1997; 1: 231-238.
5. Laszlo A, Rahman M, Espinal M, Raviglione M, and the WHO/IUATLD Network of Supranational Reference Laboratories. Quality assurance programme for drug suscepribility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Reference Laboratory Network: five rounds of proficiency testing, 1994-1998. Int J Tuberc Lung Dis 2002; 6: 748-756.
6. Migliori G B, Ambrosetti M, Fattorini L, et al. Surveillance of anti-tuberculosis drug resistance: results of the 1998/1999 proficiency testing in Italy. Int J Tuberc Lung Dis 2000; 4: 940-946.
7. Migliori G B, Centis R, Fattorini L, et al. Mycobacterium tuberculosis complex drug resistance in Italy. Emerg Infect Dis 2004; 10: 752-753.